Black and Indigenous individuals have higher overall cancer death rates, despite having lower cancer incidence rates. HealthDay News — In its biennial Cancer Disparities Progress Report published ...

Benefits include better cardiometabolic risk profile, as well as lower mortality. HealthDay News — Plant-based diets appear beneficial in lowering cardiometabolic risk factors, as well as ...

Immune-mediated adverse events were reported to be the primary reason for discontinuation in the vibostolimab/pembrolizumab coformulation arm. Merck has made the ...

The HPV self-collection solution allows an individual to collect their own vaginal sample for HPV screening while at a health care facility. The Food and Drug Administration (FDA) has approved Roche’s ...

An analysis of weight-related measures showed weight loss with semaglutide continued through week 65 and was sustained through the rest of the 4-year trial. Treatment with semaglutide 2.4mg once ...

Access to abortion has gotten tougher for American women, with 14 states now prohibiting nearly all such procedures, and 3 more banning after just 6 weeks of pregnancy. HealthDay News — While some ...

Even with health care insurance, users report difficulty paying for the medication. HealthDay News — One in 8 adults (12%) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA ...

The information provided in response to the FDA’s Complete Response Letter "constituted a major amendment to the NDA" requiring more time for review. The Food and Drug Administration (FDA) has ...

Findings showed treatment with ensitrelvir led to a reduction in the time to symptom resolution compared with placebo, however the difference was not considered statistically significant. A phase 3 ...

A PDUFA target action date of November 13, 2024 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for ...

An interim analysis showed among the 43 evaluable patients, the overall response rate was 37.2%. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to petosemtamab for ...

Odds of primary vaccine failure were increased in association with cesarean birth. HealthDay News — At the individual level, there is high predictability for measles antibody dynamics from birth, ...